Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Portfolio Pulse from
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) will participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on February 4, 2025. The company focuses on developing cancer therapeutics using its INTASYL® siRNA gene silencing technology.
February 03, 2025 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phio Pharmaceuticals is participating in a virtual roadshow to present its cancer therapeutics technology, potentially increasing investor interest.
Participation in the roadshow provides Phio Pharmaceuticals an opportunity to showcase its innovative cancer treatment technology to potential investors, which could lead to increased interest and a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100